Actinium Pharmaceuticals Inc (ATNM)

$1.42 -0.20 (-12.35%)
Market Cap 44.30M
Revenue (ttm) 0.00
Net Income (ttm) -38.24M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 4,276,900
Avg Vol 374,864
Day's Range N/A - N/A
Shares Out 31.20M
Stochastic %K 3%
Beta -0.27
Analysts Strong Sell
Price Target $5.00

Company Profile

Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. The company advances two clinical stage product candidates, Actimab-A, to treat patients with myeloid malignancies including acute myeloid leukemia and myelodysplastic syndromes; and Iomab-ACT, to improve patient access to and outcomes with cellular therapies, such as CAR-T for various blood cancer indications...

Industry: Biotechnology
Sector: Healthcare
Phone: 646 677 3870
Address:
100 Park Avenue, 23rd Floor, New York, United States
johnny4cures
johnny4cures Jun. 29 at 2:12 PM
$ATNM
0 · Reply
thagreatbul
thagreatbul Jun. 29 at 4:50 AM
$ATNM 246k shares at $1.537 avg. Let’s do this!
0 · Reply
gooddoggie
gooddoggie Jun. 28 at 10:12 PM
$ATNM Worf: I feel like we’ve done this before! Riker: Captain! We’re trapped in a highly localized distortion of the space-time continuum!
0 · Reply
StockKing_2
StockKing_2 Jun. 28 at 8:38 PM
$ATNM $NVS Watching golf at the moment and a Pluvicto ad just ran. Listing all their disclaimers and touting their 49% tumor growth inhibition. Would love to see it at 99% with help from ATNM-400!
1 · Reply
gooddoggie
gooddoggie Jun. 28 at 1:52 PM
$ATNM What hart about 2:45? It’s got to be an organized attack.
1 · Reply
resume777
resume777 Jun. 28 at 12:03 PM
$ATNM https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-eliminates-risk-evaluation-mitigation-strategies-car-t-cancer-therapies-2025-06-27/
1 · Reply
johnny4cures
johnny4cures Jun. 28 at 5:17 AM
$ATNM Intrinsic value, IV, is rising with larger patient populations right, plus soon manufacturing, supply creeping up.
0 · Reply
Pinto72
Pinto72 Jun. 28 at 4:35 AM
$IOVA AAVIE????🚀🚀🚀🚀🚀🚀🤣🤣🤣🤣🤣🤣🤣🤣 $ATNM
0 · Reply
luzongeezer
luzongeezer Jun. 28 at 1:36 AM
$ATNM Shopping for pig feed. I am not killing that pig, Glenda. When the time comes, make your brother-in-law do it!
1 · Reply
gooddoggie
gooddoggie Jun. 27 at 11:28 PM
$ATNM I also use Chat GPT.
0 · Reply
Latest News on ATNM
Actinium Highlights Expanded Data Set for ATNM-400 in Prostate Cancer Demonstrating Superior Efficacy to Enzalutamide and Ability to Overcome Resistance to ARPI Therapy and PSMA-Ac-225/Lu-177 Labelled Radiotherapy at the Society of Nuclear Medicine & Molecular Imaging Annual Meeting

Jun 23, 2025, 11:30 AM EDT - 6 days ago

Actinium Highlights Expanded Data Set for ATNM-400 in Prostate Cancer Demonstrating Superior Efficacy to Enzalutamide and Ability to Overcome Resistance to ARPI Therapy and PSMA-Ac-225/Lu-177 Labelled Radiotherapy at the Society of Nuclear Medicine & Molecular Imaging Annual Meeting

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 27, 2025 in Actinium Lawsuit - ATNM

May 22, 2025, 5:45 AM EDT - 5 weeks ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 27, 2025 in Actinium Lawsuit - ATNM

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 27, 2025 in Actinium Lawsuit – ATNM

May 15, 2025, 1:43 PM EDT - 6 weeks ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 27, 2025 in Actinium Lawsuit – ATNM

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium

May 14, 2025, 1:26 PM EDT - 6 weeks ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium

Actinium Announces Enrollment of First Patient in the Iomab-ACT Commercial CAR-T Trial at the University of Texas Southwestern Medical Center

May 6, 2025, 8:45 AM EDT - 7 weeks ago

Actinium Announces Enrollment of First Patient in the Iomab-ACT Commercial CAR-T Trial at the University of Texas Southwestern Medical Center

Lawsuit for Investors in shares of Actinium Pharmaceuticals, Inc. (NYSE: ATNM) announced by the Shareholders Foundation

Apr 30, 2025, 7:25 AM EDT - 2 months ago

Lawsuit for Investors in shares of Actinium Pharmaceuticals, Inc. (NYSE: ATNM) announced by the Shareholders Foundation

Actinium Presents Data Showing ATNM-400 is More Efficacious than Pluvicto and is Highly Efficacious after Pluvicto Resistance in Prostate Cancer Tumor Models at the American Association for Cancer Research Annual Meeting

Apr 28, 2025, 8:30 AM EDT - 2 months ago

Actinium Presents Data Showing ATNM-400 is More Efficacious than Pluvicto and is Highly Efficacious after Pluvicto Resistance in Prostate Cancer Tumor Models at the American Association for Cancer Research Annual Meeting

Actinium Highlights Mutation Agnostic Antileukemic Activity of Actimab-A Against FLT3, NPM1, KMT2A and TP53 Mutations in AML Models Demonstrating Backbone Potential for Acute Myeloid Leukemia Treatment at the American Association for Cancer Research Annual Meeting

Apr 28, 2025, 8:00 AM EDT - 2 months ago

Actinium Highlights Mutation Agnostic Antileukemic Activity of Actimab-A Against FLT3, NPM1, KMT2A and TP53 Mutations in AML Models Demonstrating Backbone Potential for Acute Myeloid Leukemia Treatment at the American Association for Cancer Research Annual Meeting

ITM and Alpha-9 Oncology Enter Into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225

Apr 24, 2025, 5:00 AM EDT - 2 months ago

ITM and Alpha-9 Oncology Enter Into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium

Apr 19, 2025, 8:20 AM EDT - 2 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 27, 2025 in Actinium Pharmaceuticals, Inc. Lawsuit - ATNM

Apr 17, 2025, 5:45 AM EDT - 2 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 27, 2025 in Actinium Pharmaceuticals, Inc. Lawsuit - ATNM

Ibotta, Inc. Investors: Company Investigated by the Portnoy Law Firm

Apr 16, 2025, 10:01 AM EDT - 2 months ago

Ibotta, Inc. Investors: Company Investigated by the Portnoy Law Firm

IBTA

Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Actinium Pharmaceuticals, Inc. (ATNM)

Mar 28, 2025, 11:57 AM EDT - 3 months ago

Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Actinium Pharmaceuticals, Inc. (ATNM)

Actinium Pharmaceuticals Announces ATNM-400 a Novel Non-PSMA Targeting First in Class Prostate Cancer Radiotherapy Leveraging Actinium-225

Mar 27, 2025, 8:45 AM EDT - 3 months ago

Actinium Pharmaceuticals Announces ATNM-400 a Novel Non-PSMA Targeting First in Class Prostate Cancer Radiotherapy Leveraging Actinium-225

Actinium Pharmaceuticals to Host KOL Investor Call at 8am ET Today to Highlight Revamped Clinical Programs and Expanded Market Opportunities Including Newly Initiated Actimab-A Solid Tumor Program

Mar 25, 2025, 6:00 AM EDT - 3 months ago

Actinium Pharmaceuticals to Host KOL Investor Call at 8am ET Today to Highlight Revamped Clinical Programs and Expanded Market Opportunities Including Newly Initiated Actimab-A Solid Tumor Program

Actinium Pharmaceuticals Announces Supply Agreement with Eckert & Ziegler for Ac-225 Radioisotope to Support Comprehensive Development Activities

Mar 24, 2025, 4:15 PM EDT - 3 months ago

Actinium Pharmaceuticals Announces Supply Agreement with Eckert & Ziegler for Ac-225 Radioisotope to Support Comprehensive Development Activities

Actinium Pharmaceuticals Announces Research Collaboration with Memorial Sloan Kettering to Support Further Clinical Expansion of Actimab-A's Backbone Therapy Strategy

Mar 20, 2025, 8:00 AM EDT - 3 months ago

Actinium Pharmaceuticals Announces Research Collaboration with Memorial Sloan Kettering to Support Further Clinical Expansion of Actimab-A's Backbone Therapy Strategy

Actinium Pharmaceuticals to Host Investor KOL Call with Dr. Ehab Atallah of the Medical College of Wisconsin and Provide a Pipeline Update Highlighting Revamped Clinical Programs and Expanded Market Opportunities for Actimab-A and Iomab-ACT with Clinical Data in 2H:2025

Mar 19, 2025, 8:30 AM EDT - 3 months ago

Actinium Pharmaceuticals to Host Investor KOL Call with Dr. Ehab Atallah of the Medical College of Wisconsin and Provide a Pipeline Update Highlighting Revamped Clinical Programs and Expanded Market Opportunities for Actimab-A and Iomab-ACT with Clinical Data in 2H:2025

Actinium Pharmaceuticals Announces Clinical Trial Program in Solid Tumors Combining Actimab-A with PD-1 Checkpoint Inhibitors KEYTRUDA® and OPDIVO®

Mar 18, 2025, 8:00 AM EDT - 3 months ago

Actinium Pharmaceuticals Announces Clinical Trial Program in Solid Tumors Combining Actimab-A with PD-1 Checkpoint Inhibitors KEYTRUDA® and OPDIVO®

johnny4cures
johnny4cures Jun. 29 at 2:12 PM
$ATNM
0 · Reply
thagreatbul
thagreatbul Jun. 29 at 4:50 AM
$ATNM 246k shares at $1.537 avg. Let’s do this!
0 · Reply
gooddoggie
gooddoggie Jun. 28 at 10:12 PM
$ATNM Worf: I feel like we’ve done this before! Riker: Captain! We’re trapped in a highly localized distortion of the space-time continuum!
0 · Reply
StockKing_2
StockKing_2 Jun. 28 at 8:38 PM
$ATNM $NVS Watching golf at the moment and a Pluvicto ad just ran. Listing all their disclaimers and touting their 49% tumor growth inhibition. Would love to see it at 99% with help from ATNM-400!
1 · Reply
gooddoggie
gooddoggie Jun. 28 at 1:52 PM
$ATNM What hart about 2:45? It’s got to be an organized attack.
1 · Reply
resume777
resume777 Jun. 28 at 12:03 PM
$ATNM https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-eliminates-risk-evaluation-mitigation-strategies-car-t-cancer-therapies-2025-06-27/
1 · Reply
johnny4cures
johnny4cures Jun. 28 at 5:17 AM
$ATNM Intrinsic value, IV, is rising with larger patient populations right, plus soon manufacturing, supply creeping up.
0 · Reply
Pinto72
Pinto72 Jun. 28 at 4:35 AM
$IOVA AAVIE????🚀🚀🚀🚀🚀🚀🤣🤣🤣🤣🤣🤣🤣🤣 $ATNM
0 · Reply
luzongeezer
luzongeezer Jun. 28 at 1:36 AM
$ATNM Shopping for pig feed. I am not killing that pig, Glenda. When the time comes, make your brother-in-law do it!
1 · Reply
gooddoggie
gooddoggie Jun. 27 at 11:28 PM
$ATNM I also use Chat GPT.
0 · Reply
Pickerbefore
Pickerbefore Jun. 27 at 10:08 PM
$ATNM lots of shares dumped today. Lots of people throughing out the TRASH. Seth should be thrown out too to complete the garbage removal.
0 · Reply
gbtrade
gbtrade Jun. 27 at 8:57 PM
$ATNM Did nobody notice the volume today? For a stock that has been barely breaking 100k daily volume for weeks to suddenly do over 4 million in a day is highly unusual!
2 · Reply
Biotrad3r
Biotrad3r Jun. 27 at 8:52 PM
$ATNM Please bring it down 🙏 will be loading up again on Monday!
1 · Reply
englishkaren
englishkaren Jun. 27 at 7:45 PM
$ATNM We need updates on the manufacturing facility
3 · Reply
englishkaren
englishkaren Jun. 27 at 7:23 PM
$ATNM FDA just removed REMS for all approved CAR-Ts More access, more patients, more decentralization. $ATNM’s Iomab-ACT is now even more relevant, a safer, targeted alternative to toxic chemo for CAR-T conditioning. Timing couldn’t be better. https://www.fiercepharma.com/pharma/fda-removes-barrier-car-t-therapies-access-boost-cancer-immunotherapy-uptake
1 · Reply
Biotrad3r
Biotrad3r Jun. 27 at 7:06 PM
$ATNM Bios getting hammered today. At least we aren't Adial Pharmaceuticals Inc (ADIL) . Rough day!
0 · Reply
Jimmy1940
Jimmy1940 Jun. 27 at 5:48 PM
$ATNM if it gets to 1.70 I'll be exactly at a 80 percent loss...wonderful
1 · Reply
tjm1
tjm1 Jun. 27 at 4:26 PM
$ATNM Next exit I hope is Seth!
0 · Reply
BruceSr
BruceSr Jun. 27 at 3:42 PM
$ATNM Has anyone done a wellness check on Doggie?…. I haven’t heard from him for awhile.
1 · Reply
Pinto72
Pinto72 Jun. 27 at 2:50 PM
$ATNM DOOOOOOOOOWN AGAIN!!!!! BANKRUPTCY AS SOON🚀🚀🚀🚀🚀🚀 eXtReEmLeE bUlLiSh🤣🤣🤣🤣🤣🤣 HELLOOOOOOOO, AAVIE!!!!!
0 · Reply
thagreatbul
thagreatbul Jun. 27 at 5:17 AM
$ATNM Next exit $2.30.
1 · Reply
MGeronimo
MGeronimo Jun. 26 at 6:38 PM
$ATNM https://stocks.apple.com/A57GTpsNbTHCbskM4cDct3A
0 · Reply